# Avicenna Biosciences

**Canonical:** https://apis.io/providers/avicenna-biosciences/  
**Website:** https://www.avicenna-bio.com/  
**APIs profiled:** 0

Avicenna Biosciences, Inc. is a Durham, North Carolina drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. Founded in 2020 and led by president and CEO Chris Meldrum, the company applies computational screening of candidate molecules for drug-like properties to the "last mile" of small molecule discovery, targeting neurodegenerative disease programs including Rho kinase inhibitors for Parkinson's disease and ALS. Avicenna raised a seed round led by DCVC Bio and has signed research collaborations with partners such as Molecure S.A. The company publishes no public developer portal, API, or machine-readable interface as of this enrichment pass; it is catalogued here as an AI-for-drug-discovery company profile rather than an API provider.

## Kin Score — 4.1 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 4.1).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Avicenna Biosciences Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biosciences, Life Sciences, Biotechnology, Venture Backed, DCVC Portfolio, Drug Discovery, Machine-Learning, Medicinal Chemistry, Small Molecule, Neurodegenerative Disease, Artificial Intelligence

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/avicenna-biosciences/). Scores are computed from the provider's own public artifacts under a published rubric.